Skip to main content

Table 5 Associations between PM stage, parasite density, doses of IPTp-SP, and low birth weight (< 2500 g) in three multivariable models

From: Risk factors for placental malaria, sulfadoxine-pyrimethamine doses, and birth outcomes in a rural to urban prospective cohort study on the Bandiagara Escarpment and Bamako, Mali

  

95% CI

 
 

OR

Lower

Upper

p-value

Infection stage (ref. None) (N = 305)

    

 Acute

1.10

0.88

1.37

0.398

 Chronic

1.46

1.25

1.70

 < 0.001

 Past

1.10

0.99

1.21

0.068

Parasite density (ref. None) (N = 305)

    

 Mild

1.05

0.90

1.24

0.534

 Moderate

1.35

1.06

1.72

0.016

 Severe

1.71

1.41

2.06

 < 0.001

IPTp-SP doses (ref. 3−) (N = 310)

    

 None

1.22

0.96

1.55

0.100

 1

1.14

1.02

1.28

0.023

 2

1.14

1.03

1.27

0.015

  1. Odds Ratios (OR) and 95% confidence intervals (CI) from general estimating equations for logistic regression adjusted for residence during pregnancy, gravidity, maternal age, sex of baby, and maternal pre-pregnancy BMI. p < 0.05 bolded. ref reference group, CI confidence interval, IPTp-SP intermittent preventative treatment in pregnancy with sulfadoxine-pyrimethamine. Intercepts were included (not shown)